Annual Drug Patent Expirations for SKLICE
Sklice is a drug marketed by Arbor Pharms Llc and is included in one NDA. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for SKLICE.
This drug has twenty-six patent family members in thirteen countries.
The generic ingredient in SKLICE is ivermectin. One supplier is listed for this compound. Additional details are available on the ivermectin profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com